Amicus Therapeutics
FOLD
#3908
Rank
$3.05 B
Marketcap
$9.90
Share price
-0.50%
Change (1 day)
1.43%
Change (1 year)

Amicus Therapeutics (FOLD) - Total debt

Total debt on the balance sheet as of September 2025 : $0.44 Billion USD

According to Amicus Therapeutics 's latest financial reports the company's total debt is $0.44 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Amicus Therapeutics - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$0.44 B-0.32%
2023-12-31$0.44 B-1.56%
2022-12-31$0.45 B2.72%
2021-12-31$0.44 B-0.36%
2020-12-31$0.44 B110.12%
2019-12-31$0.21 B-34.66%
2018-12-31$0.32 B95.98%
2017-12-31$0.16 B6.09%
2016-12-31$0.15 B271.98%
2015-12-31$41.6 M189.9%
2014-12-31$14.35 M-0.85%
2013-12-31$14.47 M1976.47%
2012-12-31$0.69 M-33.24%
2011-12-31$1.04 M-55.33%
2010-12-31$2.33 M-40.11%
2009-12-31$3.9 M226.8%
2008-12-31$1.19 M-56.12%
2007-12-31$2.72 M-23.63%
2006-12-31$3.56 M251.51%
2005-12-31$1.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
$6.59 B 1,388.21%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.60 B 36.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.30 B-30.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$23.86 B 5,288.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
$58.15 M-86.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
$15.91 B 3,494.07%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark